OLD Mutual Customised Solutions Proprietary Ltd. lifted its stake in Waters Co. (NYSE:WAT) by 65.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,800 shares of the medical instruments supplier’s stock after purchasing an additional 1,500 shares during the period. OLD Mutual Customised Solutions Proprietary Ltd.’s holdings in Waters were worth $734,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Banco de Sabadell S.A bought a new position in shares of Waters in the fourth quarter worth about $193,000. Brown Advisory Securities LLC bought a new position in shares of Waters in the fourth quarter worth about $202,000. Checchi Capital Advisers LLC bought a new position in shares of Waters in the fourth quarter worth about $210,000. Trust Co. of Virginia VA bought a new position in shares of Waters in the fourth quarter worth about $213,000. Finally, Zions Bancorporation grew its holdings in shares of Waters by 12,075.0% in the third quarter. Zions Bancorporation now owns 1,461 shares of the medical instruments supplier’s stock worth $262,000 after purchasing an additional 1,449 shares during the last quarter. Hedge funds and other institutional investors own 94.51% of the company’s stock.
A number of research analysts have recently commented on WAT shares. Zacks Investment Research upgraded shares of Waters from a “hold” rating to a “buy” rating and set a $217.00 price target on the stock in a report on Tuesday, December 26th. Morgan Stanley upgraded shares of Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 price target on the stock in a report on Monday, December 4th. BTIG Research started coverage on shares of Waters in a report on Friday, January 5th. They issued a “buy” rating and a $230.00 price target on the stock. Evercore ISI started coverage on shares of Waters in a report on Wednesday, January 3rd. They issued an “in-line” rating and a $198.00 price target on the stock. Finally, JPMorgan Chase & Co. upped their price target on shares of Waters from $180.00 to $200.00 and gave the stock a “neutral” rating in a report on Wednesday, January 24th. Twelve research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $205.13.
Shares of Waters Co. (NYSE WAT) opened at $199.51 on Monday. Waters Co. has a one year low of $153.04 and a one year high of $220.20. The firm has a market cap of $15,718.29, a PE ratio of 26.60, a P/E/G ratio of 2.39 and a beta of 0.91. The company has a quick ratio of 6.60, a current ratio of 7.04 and a debt-to-equity ratio of 0.85.
Waters (NYSE:WAT) last released its quarterly earnings data on Tuesday, January 23rd. The medical instruments supplier reported $2.51 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.44 by $0.07. Waters had a net margin of 0.88% and a return on equity of 24.70%. The company had revenue of $687.28 million during the quarter, compared to analyst estimates of $671.98 million. During the same period in the prior year, the firm earned $2.21 earnings per share. The firm’s revenue for the quarter was up 9.3% compared to the same quarter last year. analysts anticipate that Waters Co. will post 8.16 EPS for the current year.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.